| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/30/2002 | WO2001087862A3 Biologically active 4h-benzo[1,4]oxazin-3-ones |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 05/30/2002 | WO2001085149A3 Felbamate derived compounds |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001051043A3 Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols |
| 05/30/2002 | WO2001021795A9 Fatty acid transport proteins |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000060953A3 Methods for stabilizing liquid nutritional products and products so stabilized |
| 05/30/2002 | US20020065416 Anti-inflammatory agents |
| 05/30/2002 | US20020065397 Protecting therapeutic compositions from host-mediated inactivation |
| 05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065311 Comprehensive pharmacologic therapy for treatment of obesity |
| 05/30/2002 | US20020065299 Administering for therapy of mitochondria medited disease |
| 05/30/2002 | US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
| 05/30/2002 | US20020065284 Dipeptide derivatives |
| 05/30/2002 | US20020065277 Administering to an obese patient or a patient at risk of becoming obese therapeutically effective amount of compound that attenuates binding of agouti-related protein to melanocortin receptors |
| 05/30/2002 | US20020065275 To increase insulin secretion, which makes them useful for treating type II diabetes |
| 05/30/2002 | US20020065255 Disodium salt of active delivery agents (drugs) form solvates with ethanol and hydrates with water; greater efficacy for delivering active agents than monosodium salt |
| 05/30/2002 | US20020065245 Sweetener |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064556 Core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane. |
| 05/30/2002 | US20020064549 Insulin supplemented infant formula |
| 05/30/2002 | US20020064511 Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2429326A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 05/30/2002 | CA2429257A1 Antidiabetic compositions containing a biguanide and a sulfonamide |
| 05/30/2002 | CA2427661A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/30/2002 | CA2363951A1 Modulating ramp activity |
| 05/30/2002 | CA2363935A1 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 05/29/2002 | EP1208850A1 Pastes with the sustained release of osteogenesis promoter |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208838A2 Pure S(+)isomer fluoxetine |
| 05/29/2002 | EP1208701A2 Communications system |
| 05/29/2002 | EP1208384A2 Methods and compositions for modulating oxidized ldl transport |
| 05/29/2002 | EP1208377A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 05/29/2002 | EP1208242A1 Antisense modulation of pepck-mitochondrial expression |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208095A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 05/29/2002 | EP1208005A1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 05/29/2002 | EP1207896A1 Methods and compositions for reducing serum phosphate levels |
| 05/29/2002 | EP1207895A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/29/2002 | EP1207881A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 05/29/2002 | EP1207878A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207860A1 Controlled release pellet formulation |
| 05/29/2002 | EP1207853A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0923382B1 Compositions of plant carbohydrates as dietary supplements |
| 05/29/2002 | DE10055742A1 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351602A New pharmaceutically active compounds |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 05/29/2002 | CN1351496A Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 05/29/2002 | CN1351492A synergistic effects of amlodipine and atorvastatin |
| 05/29/2002 | CN1351138A Calcium-enriched wine |
| 05/29/2002 | CN1350860A Process for preparing health-care oral liquid for diabetics |
| 05/29/2002 | CN1085549C Medicinal liquor for treating hyperlipemia and hyperviscosity blood |
| 05/28/2002 | USRE37721 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/28/2002 | US6395919 Calcilytic compounds |
| 05/28/2002 | US6395785 E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 05/28/2002 | US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment |
| 05/28/2002 | US6395781 Reducing vascular diameter |
| 05/28/2002 | US6395769 2-arylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/28/2002 | US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395762 Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |
| 05/28/2002 | US6395751 Synergistic mixture; anticholesterol agents |
| 05/28/2002 | US6395734 Anticancer agents |
| 05/28/2002 | US6395727 Method of treating Bulimia Nervosa and related eating disorders by administration of atypical antipsychotic medications |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/28/2002 | US6395310 Composition containing embryo bud and seed coat from rice and fruit body of Ganoderma lucidum for treating diabetes |
| 05/28/2002 | CA2222467C Novel derivatives of benzopyrane, process for preparing them and pharmaceutical compositions containing them |
| 05/28/2002 | CA2209513C Arachidonic acid and methods for the production and use thereof |
| 05/28/2002 | CA2083274C The pharmacological use of certain cystine derivatives |
| 05/28/2002 | CA1341363C Insulinotropic hormone |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |